Treatment of Retinal Vasculitis with Significant Visual Loss, Macular Edema, and Extensive Retinal Involvement

Clinical Scenario This protocol addresses the most severe presentations of retinal vasculitis: significant loss of visual acuity accompanied by macular edema and extensive retinal involvement — a combination that requires prompt, structured systemic management.
Treatment Goals Suppression of intraocular inflammation (disease control), prevention of vision loss and long-term complications, maintenance of remission, and prevention of relapses.
Treatment Approach (partial overview) Systemic corticosteroid therapy — oral or intravenous — is indicated for this severe presentation, with gradual dose reduction once the disease is controlled.

The complete regimen, tapering schedule, and long-term management algorithm are available in the full structured protocol below.

References

  • In the most severe cases, with significant loss of visual acuity, macular edema, and extensive retinal involvement, the use of systemic corticosteroid therapy (oral or intravenous) is indicated.
  • Oral corticosteroid therapy is typically used in moderate to severe bilateral cases with significant loss of visual acuity.
  • Once the disease is controlled, medication should be gradually reduced.
DOI: 10.25259/JORP_34_2024 View source ↗